Anand Srivastava is a Nephrology physician affiliated with University of Illinois Chicago. OpenAlex indexes 192 publications with 7,790 citations (h-index 39).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
259 E Erie St
Chicago, IL 606112987
Telephone
312-695-6868Registry record last updated 21 Jul 2022.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Amgen Inc.Program year20246 payments
- Novo Nordisk IncProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using SGLT2 Inhibitors
University of Illinois at Chicago
FY2026$741,340R01HL180499 - Functional MRI to Identify High-risk CKD Phenotypes
University of Illinois at Chicago
FY2026$668,268R01DK139321 - Functional MRI to Identify High-risk CKD Phenotypes
University of Illinois at Chicago
FY2025$793,840R01DK139321
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
The Lancet Diabetes & Endocrinology
2023 - Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
The Lancet Diabetes & Endocrinology
2023 - Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19
Intensive Care Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Jerry Krishnan, MD
University of Illinois Chicago
Victor Gordeuk, MD
University of Illinois Chicago
Richard Penn, MD
University of Illinois Chicago
William Mieler, MD
University of Illinois Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”